The American Association for Cancer Research (AACR) today announced its newly elected class of Fellows of the AACR Academy.
The AACR Academy serves to recognize and honor distinguished scientists whose major scientific contributions have propelled significant innovation and progress against cancer. All Fellows are nominated and elected through a rigorous peer-review process conducted by existing Fellows of the AACR Academy and ratified by the AACR Executive Committee. This process involves an assessment of each candidate on the basis of his or her scientific achievements in cancer research and cancer-related biomedical science. Only individuals whose work has had a significant and enduring impact on the field are eligible for election as AACR Fellows.
[…] Carl H. June, MD, Richard W. Vague Professor in Immunotherapy, Department of Pathology and Laboratory Medicine; Director, Center for Cellular Immunotherapies; Director, Parker Institute for Cancer Immunotherapy, University of Pennsylvania School of Medicine, Abramson Cancer Center, Philadelphia For designing chimeric antigen receptor T cell immunotherapy for the treatment of refractory and relapsed chronic lymphocytic leukemia.